Lan Tang

Lan Tang serves as the Director of Business Development at Catalent Pharma Solutions, focusing on biologics and mRNA since May 2023. Previously, Lan held the position of Director of Business Development & Scientific Solution at GenScript ProBio, specializing in antibody discovery and large molecule development from February 2022 to April 2023. Prior experience includes roles at GenScript as a Business Development Executive and Manager of Scientific Liaison, emphasizing antibody discovery and GMP manufacturing. Additional experience includes positions at Carestream Health and VaxInnate Corporation, where Lan contributed to technical account management and research. Educational achievements include a Ph.D. in Biological Sciences from Carnegie Mellon University and a Doctor of Medicine from Nanjing Medical University.